{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:35:35Z","timestamp":1777358135035,"version":"3.51.4"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Systemic lupus erythematosus (SLE) frequently involves the hematologic system, and autoimmune hemolytic anemia (AIHA) is a severe and potentially life-threatening complication. Splenectomy has been regarded as a third-line treatment option for refractory AIHA; however, its role in SLE-associated AIHA, particularly in patients with atypical immunologic phenotypes, remains to be further clarified. Here, we report a patient with refractory SLE-associated AIHA who failed multiple lines of therapy and subsequently underwent splenectomy, after which the hemoglobin level gradually increased and sustained hematologic improvement was achieved during follow-up. Splenic pathology suggested that the spleen was not only a major site of erythrocyte destruction but also a key pathologic organ in sustaining abnormal immune responses and ongoing hemolysis. In addition, positive IFI44L methylation provided supplementary supportive evidence for an SLE-related immune background. This case suggests that splenectomy may still represent a therapeutic option worthy of careful consideration in patients with refractory SLE-associated AIHA who fail multiple lines of therapy.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1799942","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:38:19Z","timestamp":1777354699000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful splenectomy for refractory systemic lupus erythematosus\u2013associated autoimmune hemolytic anemia: a case report and mechanistic insight"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaoli","family":"Pan","sequence":"first","affiliation":[{"name":"Rheumatology and Immunology Department, the Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[{"name":"Rheumatology and Immunology Department, the Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Li","sequence":"additional","affiliation":[{"name":"Rheumatology and Immunology Department, the Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yupei","family":"Lin","sequence":"additional","affiliation":[{"name":"Rheumatology and Immunology Department, the Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Rheumatology and Immunology Department, the Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingqiao","family":"Tian","sequence":"additional","affiliation":[{"name":"Rheumatology and Immunology Department, the Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Tian","sequence":"additional","affiliation":[{"name":"Rheumatology and Immunology Department, the Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anmao","family":"Li","sequence":"additional","affiliation":[{"name":"Rheumatology and Immunology Department, the Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2015.05.001","article-title":"Immune hemolysis: Diagnosis and treatment recommendations","volume":"52","author":"Barcellini","year":"2015","journal-title":"Semin Hematol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s40001-025-02601-8","article-title":"Prevalence of systemic lupus erythematosus in autoimmune hemolytic anemia patients based on coombs test results","volume":"30","author":"Harahap","year":"2025","journal-title":"Eur J Med Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1479-2","article-title":"Autoimmune hemolytic anemia in systemic lupus erythematosus: Association with thrombocytopenia","volume":"29","author":"Domiciano","year":"2010","journal-title":"Clin Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000078","article-title":"Haematological manifestations of lupus","volume":"2","author":"Fayyaz","year":"2015","journal-title":"Lupus Sci Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14654","article-title":"Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia","volume":"177","author":"Hill","year":"2017","journal-title":"Br J Haematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1136\/annrheumdis-2015-208410","article-title":"IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus","volume":"75","author":"Zhao","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2310666120","article-title":"Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation","volume":"120","author":"Dijkstra","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102913","article-title":"Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis","volume":"21","author":"Bernardoff","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.761395","article-title":"Epitope-specific anti-C1q autoantibodies in systemic lupus erythematosus","volume":"12","author":"Kleer","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cmet.2023.03.010","article-title":"Spleen fibroblastic reticular cell-derived acetylcholine promotes lipid metabolism to drive autoreactive B cell responses","volume":"35","author":"Zeng","year":"2023","journal-title":"Cell Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03937-8","article-title":"Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial","volume":"31","author":"Feng","year":"2025","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.08.003","article-title":"New insights in systemic lupus erythematosus: From regulatory T cells to CAR-T-cell strategies","volume":"150","author":"Doglio","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.631472","article-title":"An inflammatory loop between spleen-derived myeloid cells and CD4 T cells leads to accumulation of long-lived plasma cells that exacerbates lupus autoimmunity","volume":"12","author":"Jang","year":"2021","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2020.124862","article-title":"Perfluorooctanoic acid (PFOA) exposure induces splenic atrophy via overactivation of macrophages in male mice","volume":"407","author":"Guo","year":"2021","journal-title":"J Hazard Mater"},{"key":"B15","doi-asserted-by":"publisher","first-page":"100648","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the first international consensus meeting","volume":"41","author":"J\u00e4ger","year":"2020","journal-title":"Blood Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bjh.14478","article-title":"The diagnosis and management of primary autoimmune haemolytic anaemia","volume":"176","author":"Hill","year":"2017","journal-title":"Br J Haematol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1180509","article-title":"The choice of new treatments in autoimmune hemolytic anemia: How to pick from the basket","volume":"14","author":"Berentsen","year":"2023","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1038\/s41598-019-38809-y","article-title":"Regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL\/lpr mice derived CD4+ T cells","volume":"9","author":"Hiramatsu","year":"2019","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coi.2020.10.014","article-title":"Type I interferon in the pathogenesis of systemic lupus erythematosus","volume":"67","author":"Postal","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011629","article-title":"Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease","volume":"138","author":"Liu","year":"2021","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2021.10.010","article-title":"Erythrocyte-derived mitochondria: An unexpected interferon inducer in lupus","volume":"42","author":"Morel","year":"2021","journal-title":"Trends Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100903","article-title":"Antibodies against type I IFN: The bad guys self-restrain in systemic lupus erythematosus","volume":"4","author":"Fillatreau","year":"2023","journal-title":"Cell Rep Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1799942\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:38:24Z","timestamp":1777354704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1799942\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":22,"alternative-id":["10.3389\/fimmu.2026.1799942"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1799942","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"article-number":"1799942"}}